Filing Details
- Accession Number:
- 0000899243-23-012178
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-03 21:16:11
- Reporting Period:
- 2023-05-01
- Accepted Time:
- 2023-05-03 21:16:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1206199 | G Daniel Welch | 21823 30Th Drive Se Bothell WA 98021 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-05-01 | 5,150 | $64.38 | 12,049 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-05-01 | 5,150 | $200.04 | 6,899 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-05-01 | 1,990 | $56.77 | 8,889 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-05-01 | 1,990 | $200.12 | 6,899 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-01 | 295 | $200.06 | 6,604 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-01 | 4,890 | $200.06 | 18,170 | No | 4 | S | Indirect | by Trust |
| Common Stock | Acquisiton | 2023-05-02 | 1,888 | $64.38 | 8,492 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-05-02 | 1,888 | $200.05 | 6,604 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-05-02 | 3,171 | $160.33 | 9,775 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-05-02 | 3,171 | $200.05 | 6,604 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-05-02 | 3,462 | $147.50 | 10,066 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-05-02 | 3,462 | $200.10 | 6,604 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-02 | 351 | $200.07 | 6,253 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-05-02 | 5,835 | $200.07 | 12,335 | No | 4 | S | Indirect | by Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | by Trust |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | by Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-05-01 | 1,990 | $0.00 | 1,990 | $56.77 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-05-01 | 5,150 | $0.00 | 5,150 | $64.38 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-05-02 | 1,888 | $0.00 | 1,888 | $64.38 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-05-02 | 3,171 | $0.00 | 3,171 | $160.33 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-05-02 | 3,462 | $0.00 | 3,462 | $147.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2028-05-18 | No | 4 | M | Direct | |
| 1,888 | 2029-05-20 | No | 4 | M | Direct | |
| 0 | 2029-05-20 | No | 4 | M | Direct | |
| 0 | 2030-05-15 | No | 4 | M | Direct | |
| 0 | 2031-05-14 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- Sales reported in this Form 4 were effected pursuant to written plans, entered into on September 7, 2022, that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
- Reflects sales of common stock executed in multiple transactions at prices ranging from $200.02 to $200.06. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $200.03 to $200.41. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $200.02 to $200.41. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $200.02 to $200.43. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $200.04 to $200.05. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $200.04 to $200.08. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $200.05 to $200.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $200.04 to $200.16 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Options vested in full on 5/18/19.
- Options vested in full on 5/20/20.
- Options vested in full on 5/15/21.
- Options vested in full on 5/14/22.
Billionaire Hedge Funds
